| Genomic Health to Present at Two Upcoming Investor Conferences (PR Newswire) Genomic Health, Inc. today announced that members of its management team will present at the following conferences in June: us.rd.yahoo.com |
Weikang Bio-Tech Could Be a Winning Investment While the the GeoTeam's shift in strategy to increase its exposure to US stocks is still intact, select ChinaHybrids may still be able to perform in 2010 by bucking the short-term trend of subpar EPS growth issues caused by recent dilution activities.One stock on our list that may fit this bill is Weikang Bio-Tech Group (WKBT.OB).Complete Story » seekingalpha.com |
Good News for Cell Therapeutics Zacks.com submits: Cell Therapeutics Inc. (CTIC) received a boost when the European Medicines Agency (EMEA) validated the expanded Pediatric Investigation Plan (PIP) filed by the company in July this year for its lead candidate pixantrone. The candidate is being developed for the treatment of relapsed or refractory, aggressive non-Hodgkin's lymphoma (NHL) in patients who have not responded to other treatment options. The PIP provides the outline of the process that the company intends to follow to study the drug in children. The validation of the PIP is an important step toward the submission of a Marketing Authorization Application (MAA) and the subsequent approval for pixantrone. Following the validation, the Pediatric Committee (PDCO) of the EMEA will scrutinize the PIP and comment on or approve the content of the plan. The approval of the PIP will enable the company to submit the MAA for its lead candidate in Europe later in the year. The pediatric program intends to evaluate the safety and efficacy of pixantrone compared to chemotherapy drug doxorubicin in children (aged between 6 months and 18 years).Complete Story » seekingalpha.com |
Genzyme Sells Genetics Unit Genzyme is selling its genetic-testing business to Laboratory Corp. of America Holdings for $925 million. online.wsj.com |
Exercise Combination Cuts Blood Sugar in Type 2 Diabetics Combining aerobic exercise and resistance training lowered blood sugar levels in people with type 2 diabetes, a new study has found. online.wsj.com |